Altered Urinary Amino Acids in Children With Autism Spectrum Disorders

Autism spectrum disorders (ASD) affect 1% of children. Although there is no cure, early diagnosis and behavioral intervention can relieve the symptoms. The clinical heterogeneity of ASD has created a need for improved sensitive and specific laboratory diagnostic methods. Liquid chromatography-tandem...

Full description

Bibliographic Details
Main Authors: Aiping Liu, Wei Zhou, Liuhong Qu, Fusheng He, Hui Wang, Yan Wang, Chunquan Cai, Xiaoge Li, Wenhao Zhou, Mingbang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fncel.2019.00007/full
_version_ 1819364767483035648
author Aiping Liu
Wei Zhou
Liuhong Qu
Fusheng He
Hui Wang
Yan Wang
Chunquan Cai
Xiaoge Li
Wenhao Zhou
Mingbang Wang
author_facet Aiping Liu
Wei Zhou
Liuhong Qu
Fusheng He
Hui Wang
Yan Wang
Chunquan Cai
Xiaoge Li
Wenhao Zhou
Mingbang Wang
author_sort Aiping Liu
collection DOAJ
description Autism spectrum disorders (ASD) affect 1% of children. Although there is no cure, early diagnosis and behavioral intervention can relieve the symptoms. The clinical heterogeneity of ASD has created a need for improved sensitive and specific laboratory diagnostic methods. Liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based analysis of the metabolome has shown great potential to uncover biomarkers for complex diseases such as ASD. Here, we used a two-step discovery–validation approach to identify potential novel metabolic biomarkers for ASD. Urine samples from 57 children with ASD and 81 matched children with typical development (TD) were analyzed by LS-MS/MS to assess differences in urinary amino acids and their metabolites (referred to as UAA indicators). A total of 63 UAA indicators were identified, of which 21 were present at significantly different levels in the urine of ASD children compared with TD children. Of these 21, the concentrations of 19 and 10 were higher and lower, respectively, in the urine of ASD children compared with TD children. Using support vector machine modeling and receiver operating characteristic curve analysis, we identified a panel of 7 UAA indicators that discriminated between the samples from ASD and TD children (lysine, 2-aminoisobutyric acid, 5-hydroxytryptamine, proline, aspartate, arginine/ornithine, and 4-hydroxyproline). Among the significantly changed pathways in ASD children were the ornithine/urea cycle (decreased levels of the excitatory amino acid aspartate [p = 2.15 × 10-10] and increased arginine/ornithine [p = 5.21 × 10-9]), tryptophan metabolism (increased levels of inhibitory 5-hydroxytryptamine p = 3.62 × 10-9), the methionine cycle (increased methionine sulfoxide [p = 1.46 × 10-10] and decreased homocysteine [p = 2.73 × 10-7]), and lysine metabolism (reduced lysine [p = 7.8 × 10-9], α-aminoadipic acid [p = 1.16 × 10-9], and 5-aminovaleric acid [p = 1.05 × 10-5]). Collectively, the data presented here identify a possible imbalance between excitatory and inhibitory amino acid metabolism in ASD children. The significantly altered UAA indicators could therefore be potential diagnostic biomarkers for ASD.
first_indexed 2024-12-24T23:04:10Z
format Article
id doaj.art-b89590d01ee14ecd810ac3e4fa6533d6
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-12-24T23:04:10Z
publishDate 2019-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-b89590d01ee14ecd810ac3e4fa6533d62022-12-21T16:35:03ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022019-01-011310.3389/fncel.2019.00007408936Altered Urinary Amino Acids in Children With Autism Spectrum DisordersAiping Liu0Wei Zhou1Liuhong Qu2Fusheng He3Hui Wang4Yan Wang5Chunquan Cai6Xiaoge Li7Wenhao Zhou8Mingbang Wang9Shiyan Prevention and Health Care Center of Shenzhen, Shenzhen, ChinaDivision of Neonatology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, ChinaDivision of Neonatology, The Maternal and Child Health Care Hospital of Huadu District, Huadu Affiliated Hospital of Guangdong Medical University, Guangzhou, ChinaImunobio, Shenzhen, ChinaXiamen Branch of Children’s Hospital of Fudan University (Xiamen Children’s Hospital), Xiamen, ChinaDivision of Neonatology, The Maternal and Child Health Care Hospital of Huadu District, Huadu Affiliated Hospital of Guangdong Medical University, Guangzhou, ChinaDivision of Neurosurgery, Tianjin Children’s Hospital, Tianjin, ChinaTianjin Jinnan Xiaozhan Hospital, Tianjin, ChinaShanghai Key Laboratory of Birth Defects, Division of Neonatology, Children’s Hospital of Fudan University, National Center for Children’s Health, Shanghai, ChinaShanghai Key Laboratory of Birth Defects, Division of Neonatology, Xiamen Branch of Children’s Hospital of Fudan University (Xiamen Children’s Hospital), Children’s Hospital of Fudan University, National Center for Children’s Health, Shanghai, ChinaAutism spectrum disorders (ASD) affect 1% of children. Although there is no cure, early diagnosis and behavioral intervention can relieve the symptoms. The clinical heterogeneity of ASD has created a need for improved sensitive and specific laboratory diagnostic methods. Liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based analysis of the metabolome has shown great potential to uncover biomarkers for complex diseases such as ASD. Here, we used a two-step discovery–validation approach to identify potential novel metabolic biomarkers for ASD. Urine samples from 57 children with ASD and 81 matched children with typical development (TD) were analyzed by LS-MS/MS to assess differences in urinary amino acids and their metabolites (referred to as UAA indicators). A total of 63 UAA indicators were identified, of which 21 were present at significantly different levels in the urine of ASD children compared with TD children. Of these 21, the concentrations of 19 and 10 were higher and lower, respectively, in the urine of ASD children compared with TD children. Using support vector machine modeling and receiver operating characteristic curve analysis, we identified a panel of 7 UAA indicators that discriminated between the samples from ASD and TD children (lysine, 2-aminoisobutyric acid, 5-hydroxytryptamine, proline, aspartate, arginine/ornithine, and 4-hydroxyproline). Among the significantly changed pathways in ASD children were the ornithine/urea cycle (decreased levels of the excitatory amino acid aspartate [p = 2.15 × 10-10] and increased arginine/ornithine [p = 5.21 × 10-9]), tryptophan metabolism (increased levels of inhibitory 5-hydroxytryptamine p = 3.62 × 10-9), the methionine cycle (increased methionine sulfoxide [p = 1.46 × 10-10] and decreased homocysteine [p = 2.73 × 10-7]), and lysine metabolism (reduced lysine [p = 7.8 × 10-9], α-aminoadipic acid [p = 1.16 × 10-9], and 5-aminovaleric acid [p = 1.05 × 10-5]). Collectively, the data presented here identify a possible imbalance between excitatory and inhibitory amino acid metabolism in ASD children. The significantly altered UAA indicators could therefore be potential diagnostic biomarkers for ASD.https://www.frontiersin.org/article/10.3389/fncel.2019.00007/fullASDurinary amino acidsmetabolomeLC-MS/MSchildren
spellingShingle Aiping Liu
Wei Zhou
Liuhong Qu
Fusheng He
Hui Wang
Yan Wang
Chunquan Cai
Xiaoge Li
Wenhao Zhou
Mingbang Wang
Altered Urinary Amino Acids in Children With Autism Spectrum Disorders
Frontiers in Cellular Neuroscience
ASD
urinary amino acids
metabolome
LC-MS/MS
children
title Altered Urinary Amino Acids in Children With Autism Spectrum Disorders
title_full Altered Urinary Amino Acids in Children With Autism Spectrum Disorders
title_fullStr Altered Urinary Amino Acids in Children With Autism Spectrum Disorders
title_full_unstemmed Altered Urinary Amino Acids in Children With Autism Spectrum Disorders
title_short Altered Urinary Amino Acids in Children With Autism Spectrum Disorders
title_sort altered urinary amino acids in children with autism spectrum disorders
topic ASD
urinary amino acids
metabolome
LC-MS/MS
children
url https://www.frontiersin.org/article/10.3389/fncel.2019.00007/full
work_keys_str_mv AT aipingliu alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders
AT weizhou alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders
AT liuhongqu alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders
AT fushenghe alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders
AT huiwang alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders
AT yanwang alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders
AT chunquancai alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders
AT xiaogeli alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders
AT wenhaozhou alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders
AT mingbangwang alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders